Search Results - "Gaál, L."

Selection of intense rainfall events based on intensity thresholds and lightning data in Switzerland by Gaál, L, Molnar, P, Szolgay, J

“…This paper presents a method to identify intense warm season storms with convective character based on intensity thresholds and the presence of lightning, and…”
Get full text

Region-of-influence approach to a frequency analysis of heavy precipitation in Slovakia by Gaál, L., Kyselý, J., Szolgay, J.

“…The paper compares different approaches to regional frequency analysis with the main focus on the implementation of the region-of-influence (ROI) technique for…”
Get full text

Comparison of region-of-influence methods for estimating high quantiles of precipitation in a dense dataset in the Czech Republic by Gaal, L, Kysely, J

“…In this paper, we implement the region-of-influence (ROI) approach for modelling probabilities of heavy 1-day and 5-day precipitation amounts in the Czech…”
Get full text

Storm type effects on super Clausius–Clapeyron scaling of intense rainstorm properties with air temperature by Molnar, P, Fatichi, S, Gaál, L, Szolgay, J, Burlando, P

“…Extreme precipitation is thought to increase with warming at rates similar to or greater than the water vapour holding capacity of the air at ~ 7% °C−1, the…”
Get full text

Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future by Verhaegen, A., Van Gaal, L.

“…Summary The prevalence of non‐cigarette tobacco use in electronic cigarettes, also called vaping, is rapidly increasing, especially in adolescents and young…”
Get full text

Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population by Meijnikman, A S, De Block, C E M, Dirinck, E, Verrijken, A, Mertens, I, Corthouts, B, Van Gaal, L F

“…Objective: Type 2 diabetes (T2DM) is known to be underdiagnosed. Tests for diagnosis include fasting plasma glucose (FPG), oral glucose tolerance test (OGTT)…”
Get full text

Bayesian MCMC approach to regional flood frequency analyses involving extraordinary flood events at ungauged sites by Gaume, E., Gaál, L., Viglione, A., Szolgay, J., Kohnová, S., Blöschl, G.

“…This paper proposes a method for using major flash flood events occurred at ungauged catchments to reduce the uncertainties in estimating regional flood…”
Get full text

Dependence between flood peaks and volumes: a case study on climate and hydrological controls by Gaál, L., Szolgay, J., Kohnová, S., Hlavčová, K., Parajka, J., Viglione, A., Merz, R., Blöschl, G.

“…The aim of this paper is to understand the causal factors controlling the relationship between flood peaks and volumes in a regional context. A case study is…”
Get full text

Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options by Verhaegen, A. A., Van Gaal, L. F.

“…Weight gain is a common side effect of many widely used drugs. Weight gain of a few kilograms to an increase of 10% or more of initial body weight has been…”
Get full text

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial by Masmiquel, L, Leiter, L A, Vidal, J, Bain, S, Petrie, J, Franek, E, Raz, I, Comlekci, A, Jacob, S, van Gaal, L, Baeres, F M M, Marso, S P, Eriksson, M

“…Epidemiological data on obesity are needed, particularly in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular (CV) risk. We used the…”
Get full text

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function by Hectors, T. L. M., Vanparys, C., van der Ven, K., Martens, G. A., Jorens, P. G., Van Gaal, L. F., Covaci, A., De Coen, W., Blust, R.

“…The prevalence of diabetes mellitus is currently at epidemic proportions and it is estimated that it will increase even further over the next decades. Although…”
Get full text

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide by Astrup, A, Carraro, R, Finer, N, Harper, A, Kunesova, M, Lean, M E J, Niskanen, L, Rasmussen, M F, Rissanen, A, Rössner, S, Savolainen, M J, Van Gaal, L

“…Objective: Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and…”
Get full text

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults by Lean, M E J, Carraro, R, Finer, N, Hartvig, H, Lindegaard, M L, Rössner, S, Van Gaal, L, Astrup, A

“…Background: Liraglutide 3.0 mg, with diet and exercise, produced substantial weight loss over 1 year that was sustained over 2 years in obese non-diabetic…”
Get full text

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH by Boursier, J., Anty, R., Vonghia, L., Moal, V., Vanwolleghem, T., Canivet, C. M., Michalak, S., Bonnafous, S., Michielsen, P., Oberti, F., Iannelli, A., Van Gaal, L., Patouraux, S., Blanchet, O., Verrijken, A., Gual, P., Rousselet, M.‐C., Driessen, A., Hunault, G., Bertrais, S., Tran, A., Calès, P., Francque, S.

“…Summary Background The composite histological endpoint comprising nonalcoholic steatohepatitis (NASH) and NAFLD activity score ≥4 and advanced fibrosis (F ≥ 2)…”
Get full text

Assessing the impact of complications on the costs of Type II diabetes by WILLIAMS, R, VAN GAAL, L, LUCIONI, C

“…'The Cost of Diabetes in Europe - Type II (CODE-2) study' provides the first coordinated attempt to assess the total costs of managing people with Type II…”
Get full text

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects by WILDING, J, VAN GAAL, L, RISSANEN, A, VERCRUYSSE, F, FITCHET, M

“…Treatment of obese subjects with topiramate has recently been associated with significant weight loss in a 6-month dose-ranging study. To investigate the…”
Get full text

Obesity, haemostasis and the fibrinolytic system by Mertens, I., Gaal, L. F. Van

“…Summary Obese patients are at risk for the development of cardiovascular diseases, which can in part be explained by disturbances in the haemostatic and…”
Get full text

Sarcopenia in patients with non‐alcoholic fatty liver disease: is it a clinically significant entity? by De Fré, C. H., De Fré, M. A., Kwanten, W. J., Op de Beeck, B. J., Van Gaal, L. F., Francque, S. M.

“…Summary Sarcopenia, described as the loss of muscle mass and/or strength, is gaining importance as it can be increasingly related to many chronic diseases. It…”
Get full text

Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss by Dirinck, E, Dirtu, A. C, Jorens, P. G, Malarvannan, G, Covaci, A, Van Gaal, L. F

“…Context: Polychlorinated biphenyls (PCBs), are implicated as potential endocrine disruptors and obesogens. These lipophilic substances are preferentially…”
Get full text

Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance by Borel, A-L, Nazare, J-A, Smith, J, Aschner, P, Barter, P, Van Gaal, L, Eng Tan, C, Wittchen, H-U, Matsuzawa, Y, Kadowaki, T, Ross, R, Brulle-Wohlhueter, C, Alméras, N, Haffner, S M, Balkau, B, Després, J-P

“…Objectives: To examine the specific distribution of liver fat content, visceral and subcutaneous adiposity in normal glucose tolerance (NGT/NGT), isolated…”
Get full text